Methods of treating an IL-17A mediated pathological condition
US9890219B2 · kind B2 · utility
1Cited by
2References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 7, 2015 |
| Grant date | Feb 13, 2018 |
| Priority date | — |
| Expiry date | May 7, 2035 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to antibody molecules having specificity for antigenic determinants of both IL-17A and IL-17F, therapeutic uses of the antibody molecules and methods for producing said antibody molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.